Thyroid Disease News

JAMA IM Editor Recaps 2023's High-Impact Research Sharon K. Inouye, MD, MPH, editor in chief of JAMA Internal Medicine, discusses five of the journal's most impactful studies from 2023 and the take-home messages for internists and their colleagues.
MDedge News, January 03, 2024
Thyroidectomy Beneficial but Risky for Hashimoto Disease Unconventional approach leads to improved general health scores but "unacceptably high" 14% complication rate.
Medscape Medical News, December 20, 2023
Study Suggests Inappropriate Use of Thyroid Ultrasounds Of all new, dedicated thyroid ultrasounds performed at a single tertiary care center, only a quarter identified biopsy-recommended nodules, whereas nearly 40% did not find any nodules.
Medscape Medical News, December 18, 2023
1 in 3 Women Have Lasting Health Problems After Giving Birth More than 1 in 3 women worldwide (at least 40 million women) annually experience lasting health problems in the months or years following childbirth.
WebMD Health News, December 12, 2023
France's First Larynx Transplant The patient who received the first larynx transplant to be performed in France is recovering well and beginning to regain the use of her voice.
Medscape Medical News, December 05, 2023
No Benefit of Levothyroxine in Heart Donors New data challenge the common practice of levothyroxine administration in potential heart donors after brain death to preserve heart function and make more hearts available for transplantation.
Medscape Medical News, December 04, 2023
What Is the Dark Side of GLP-1 Receptor Agonists? Doctors who prescribe this class of medication should be aware of the rare side effects with which it is associated, said an obesity expert.
Medscape Medical News, December 01, 2023
DMARDs Linked to Reduced Thyroid Disease Incidence In a large Swedish rheumatoid arthritis cohort, the incidence of thyroid disease declines after RA diagnosis vs the general population, with the effect strongest among those treated with anti-rheumatic drugs.
Medscape Medical News, November 29, 2023
Are We Ready for Systematic Newborn Genome Sequencing? Routine sampling and analysis of newborn DNA would enable screening for hundreds of childhood genetic diseases, but also raises concerns about privacy and ethics.
Medscape Medical News, November 21, 2023
Senator Expresses 'Disappointment' in FTC's Amgen Decision Senator Elizabeth Warren, an antitrust hawk, expressed disappointment with the US Federal Trade Commission's decision to allow pharmaceutical firm Amgen to move forward with its acquisition of Horizon Therapeutics.
Reuters Health Information, November 09, 2023
Alert FDA Approves Tirzepatide for Treating Obesity Tirzepatide, the active ingredient in Eli Lilly’s Zepbound, is already approved under the name Mounjaro for the treatment of type 2 diabetes.
Medscape Medical News, November 08, 2023
Pervasive 'Forever Chemicals' Linked to Thyroid Cancer? A small study suggests that environmental PFAS exposure may raise the risk for thyroid cancer. But a biostatistician who reviewed the findings is not convinced.
Medscape Medical News, November 07, 2023
Thyroid Hormones May Increase Risk for Cognitive Disorders Overtreating older patients with the drugs was associated with cognitive disorders, according to a new study.
Medscape Medical News, November 02, 2023
Alert Pembrolizumab Wins Biliary Tract Cancer Indication The new approval is the sixth gastrointestinal indication for the checkpoint inhibitor.
FDA Approvals, November 01, 2023
ESMO 2023 PD-1 Inhibitor Improves Outcomes in NHL Subtype Treatment with the PD-1 inhibitor toripalimab plus radiation therapy improved outcomes in patients with a subtype of non-Hodgkin lymphoma, new data show.
MDedge News, November 01, 2023
Older Adults at Risk From Inappropriate Prescribing Clinicians have work to do when prescribing appropriately to older adults.
Medscape Medical News, November 01, 2023
Urgent Need to Improve Early Detection of MCI in Primary Care A US study has revealed major gaps in the detection of mild cognitive impairment in primary care, with the vast majority of older adults with the condition undiagnosed.
Medscape Medical News, October 31, 2023
Latest Evidence on Hyperthyroidism Symptoms, Treatment If left untreated, hyperthyroidism can lead to cardia arrhythmias and osteoporosis. A new review summarizes recent evidence regarding the treatment of hyperthyroidism.
Medscape Medical News, October 30, 2023
GLP-1s Like Semaglutide: Less Thyroid Cancer Than Insulin Among people with type 2 diabetes who received a GLP-1 receptor agonist, there was less correlation between this treatment and thyroid cancer than among people with type 2 diabetes treated with insulin.
Medscape Medical News, October 25, 2023
ESMO 2023 Does Adding Pembro Improve PFS in High-Risk Cervical Cancer? Pembrolizumab improved progression-free survival when added to standard chemoradiotherapy in newly diagnosed, locally advanced cervical cancer, new data show.
MDedge News, October 22, 2023
Navigating Key Endpoints in Oncology Clinical Trials Here's a guide to understanding endpoints you will likely encounter in cancer clinical trials.
Medscape Medical News, October 18, 2023
ESMO 2023 ESMO 2023: A Wealth of New Data Across Cancer Types The march of immunotherapy into a wider range of malignancies, as well as the smarter use of chemotherapy and novel targeted drugs, will be among the key highlights at the ESMO Congress 2023.
Medscape Medical News, October 11, 2023
ATA 2023 Nonsurgical Option for More Large Thyroid Nodule Patients? When considering all large thyroid nodules > 4 cm, false negative rates declined compared with considering only large nodules in patients that had undergone surgery, in a new analysis.
Medscape Medical News, October 11, 2023
Illicit Steroids: If MDs Don't Ask, Patients Won't Tell If clinicians are uncomfortable addressing use of anabolic-androgen steroids, patients will continue to look to each other and the internet to fill the void.
Medscape Medical News, October 10, 2023
ATA 2023 Thyroid Cancer Increase Observed in Transgender Female Veterans Thyroid cancer rates among transgender female veterans appear similar to those in cisgender women. Experts urge a cautious interpretation of the recent study results.
Medscape Medical News, October 05, 2023

No Results